Lupin launches generic version of Oracea capsules in US

The company said it has launched the medication, indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea, following approval from the US Food and Drug Administration (USFDA).

PTI

April 10, 2024 / 18:21 IST

Lupin, Glenmark recall drugs in US market: USFDA

live

bselive
nselive

Volume

Todays L/H

Drug maker Lupin on Wednesday said it has launched the generic version of Oracea capsules in the US market.

The company said it has launched the medication, indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea, following approval from the US Food and Drug Administration (USFDA).

As per the IQVIA MAT data, Doxycycline capsules (Oracea) had estimated annual sales of USD 128 million in the US.

Shares of the company were trading 0.77 per cent up at Rs 1,617.35 apiece on the BSE.

PTI

first published: Apr 10, 2024 11:52 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347